Skip to main content

People in the News: Ralf Huss

Premium

Definiens has tapped Ralf Huss to serve as its chief medical officer. In this position, Huss will play a key role in expanding the company's reach in the image and data analysis market, the company said.

Huss is a surgical and anatomical pathologist with more than 20 years of training and experience in histopathology and cancer research. Prior to joining Definiens, he served as the global head of the histopathology and tissue biomarker arm at Roche Diagnostics. He also co-founded Apceth, a German biotech company, and he holds academic appointments at the Ludwig-Maximilians-University in Munich and the Wake Forest Institute for Regenerative Medicine.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.